Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AZN

Astrazeneca plc ADR

Dec 07 • 04:00PM ET

63.51

Dollar change -0.08
Percentage change -0.13	%

Healthcare • Drug Manufacturers - General • United Kingdom • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	NDX	P/E	33.59	EPS (ttm)	1.89	Insider Own	0.04%	Shs Outstand	3.10B	Perf Week	-1.67%
Market Cap	196.87B	Forward P/E	15.20	EPS next Y	4.18	Insider Trans	0.00%	Shs Float	3.10B	Perf Month	-0.16%
Income	5.90B	PEG	2.60	EPS next Q	0.76	Inst Own	16.17%	Short Float / Ratio	0.26% / 1.48	Perf Quarter	-6.90%
Sales	44.99B	P/S	4.38	EPS this Y	9.83%	Inst Trans	-2.09%	Short Interest	8.10M	Perf Half Y	-14.46%
Book/sh	12.00	P/B	5.29	EPS next Y	14.21%	ROA	6.20%	Target Price	82.65	Perf Year	-7.37%
Cash/sh	1.65	P/C	38.49	EPS next 5Y	12.90%	ROE	16.30%	52W Range	61.73 - 76.56	Perf YTD	-6.33%
Dividend	1.52	P/FCF	20.95	EPS past 5Y	-2.17%	ROI	9.80%	52W High	-17.05%	Beta	0.50
Dividend %	2.39%	Quick Ratio	0.60	Sales past 5Y	15.24%	Gross Margin	71.08%	52W Low	2.88%	ATR	1.01
Employees	83500	Current Ratio	0.79	Sales Q/Q	4.64%	Oper. Margin	16.34%	RSI (14)	45.17	Volatility	1.08% 1.23%
Optionable	Yes	Debt/Eq	0.77	EPS Q/Q	-16.27%	Profit Margin	13.10%	Rel Volume	1.13	Prev Close	63.59
Shortable	Yes	LT Debt/Eq	0.62	Earnings	Nov 09 BMO	Payout	133.71%	Avg Volume	5.47M	Price	63.51
Recom	1.29	SMA20	-0.69%	SMA50	-2.23%	SMA200	-7.73%	Volume	6,194,075	Change	-0.13%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-25-23	Upgrade	Jefferies	Hold → Buy	$66.50 → $80
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-12-23	Upgrade	UBS	Neutral → Buy
Jul-05-23	Downgrade	Deutsche Bank	Buy → Hold
Apr-11-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-05-23	Initiated	BMO Capital Markets	Outperform	$82
Sep-15-22	Downgrade	Credit Suisse	Outperform → Neutral
Sep-07-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-29-22	Upgrade	Argus	Hold → Buy	$75
Jun-14-22	Downgrade	UBS	Buy → Neutral
Feb-11-22	Upgrade	DZ Bank	Sell → Hold
Dec-07-21	Downgrade	Jefferies	Buy → Hold
Aug-12-21	Resumed	JP Morgan	Overweight
Apr-12-21	Downgrade	Argus	Buy → Hold
Mar-16-21	Upgrade	Jefferies	Hold → Buy
Feb-25-21	Upgrade	UBS	Neutral → Buy
Jan-15-21	Initiated	Deutsche Bank	Buy
Dec-07-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-30-20	Upgrade	UBS	Sell → Neutral
Nov-11-20	Upgrade	HSBC Securities	Reduce → Hold

Show Previous Ratings

Today 03:54PM	UPDATE 2-US urges makers of infant RSV shots to meet winter demand (Reuters)
02:03PM	FTC warns pharma companies on excessive drug patenting (Yahoo Finance Video)
Dec-06-23 03:46AM	Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas (PR Newswire)
Dec-05-23 09:00AM	AstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
05:16AM	These 3 stocks are Cowens best ideas for 2024 including AstraZeneca and Datadog (TipRanks)
06:18AM	Loading…
Dec-04-23 06:18AM	AstraZeneca inks $247M, AI-enabled oncology antibody design pact, joining Absci's list of pharma allies (FierceBiotech.com)
Dec-03-23 01:27AM	AstraZeneca, AI biologics firm Absci tie up on cancer drug (Reuters)
01:22AM	UPDATE 2-AstraZeneca, AI biologics firm Absci tie up on cancer drug (Reuters)
12:21AM	AstraZeneca ties up with AI biologics company to develop cancer drug - FT (Reuters)
12:00AM	AstraZeneca ties up with AI biologics company to develop cancer drug (Financial Times)
Dec-01-23 01:00PM	Directors Deals: Strategy refresh spurs Unilever directors (Financial Times)
11:27AM	AstraZeneca (AZN) to Discontinue Two Studies on Lokelma (Zacks)
Nov-30-23 11:04AM	UPDATE 1-Turkey launches investigation into 19 pharma companies (Reuters)
08:00AM	Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO Technology (PR Newswire)
Nov-29-23 04:57PM	17 Best European Countries to Move to from the USA (Insider Monkey)
07:00AM	Loading…
07:00AM	AstraZeneca advances scientific leadership in hematology at ASH 2023 (Business Wire)
Nov-28-23 05:59PM	15 Hardest Countries to Get Citizenship in Europe (Insider Monkey)
10:25AM	UPDATE 2-White House urges RSV immunization makers to meet demand (Reuters)
04:30AM	30 Countries with the Highest Quality of Life Heading into 2024 (Insider Monkey)
Nov-27-23 01:37PM	Tesla sues Sweden in bid to avoid hit from strikes (The Telegraph)
05:48AM	AstraZeneca pays $24M to join race for next big KRAS opportunity, bagging Chinese rival to Mirati asset (FierceBiotech.com)
Nov-26-23 03:11PM	12 Best Diabetes Stocks To Buy Now (Insider Monkey)
06:51AM	15 Best Drug Stocks To Invest In (Insider Monkey)
Nov-24-23 09:00AM	Investors Heavily Search AstraZeneca PLC (AZN): Here is What You Need to Know (Zacks)
Nov-22-23 08:15AM	Eli Lilly and Novo Nordisk Are Big Names in Weight Loss, but Investors Shouldn't Count Out This Healthcare Giant (Motley Fool)
08:10AM	AstraZeneca fights accusations its Covid-19 jab was defective (Financial Times)
05:21AM	3 No-Brainer Stocks to Buy With $1,000 Right Now (Motley Fool)
Nov-21-23 09:40AM	Here's Why Astrazeneca (AZN) is a Strong Value Stock (Zacks)
Nov-20-23 08:27AM	AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes (Business Wire)
07:48AM	12 European Countries with the Best Quality of Life (Insider Monkey)
06:52AM	Loading…
06:52AM	20 Most Valuable Healthcare Companies in the World (Insider Monkey)
05:07AM	AstraZeneca creates digital health unit, with big-name partnerships already in place (BioPharma Dive)
Nov-17-23 09:53AM	AstraZeneca Is Trying to Make an Ozempic Competitor (Again), but Don't Rush to Buy the Stock (Motley Fool)
08:06AM	AstraZeneca's (AZN) Capivasertib Gets FDA Nod for Breast Cancer (Zacks)
07:00AM	TRUQAP (capivasertib) plus fulvestrant approved in the US for patients with advanced HR-positive breast cancer (Business Wire)
Nov-16-23 05:26PM	UPDATE 2-US FDA approves AstraZeneca's breast cancer drug combination (Reuters)
05:17PM	US FDA approves AstraZeneca's breast cancer drug combination (Reuters)
02:20PM	CORRECTED-UPDATE 2-CDC expedites release of 77,000 additional doses of Sanofi-AstraZeneca's RSV drug (Reuters)
02:10PM	CORRECTED-CDC expedites release of 77,000 additional doses of Sanofi-AstraZeneca's RSV drug (Reuters)
10:43AM	AstraZeneca's Koselugo not a 'meaningful barrier' to SpringWorks' rare disease offering, executives say (FierceBiotech.com)
Nov-15-23 10:10AM	AstraZeneca's (AZN) Imfinzi Early-Stage Lung Cancer Study Fails (Zacks)
02:30AM	Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca (GlobeNewswire)
Nov-14-23 01:30AM	AstraZeneca Targets New Pill as Cheaper Option for Losing a Bit of Weight (Barrons.com)
Nov-13-23 06:03PM	11 Best European Stocks To Buy Now (Insider Monkey)
09:00AM	Here is What to Know Beyond Why AstraZeneca PLC (AZN) is a Trending Stock (Zacks)
Nov-10-23 02:51PM	AstraZeneca PLC (NASDAQ:AZN) Q3 2023 Earnings Call Transcript (Insider Monkey)
02:18PM	AstraZeneca prioritizes US for RSV drug amid surge in cases (Reuters)
11:38AM	AstraZeneca's long-term GLP-1 play is weight management, not obesity, CEO says (FierceBiotech.com)
08:35AM	Weight-loss drug maker to spend £4.9bn on new facilities amid surging demand (The Telegraph)
08:35AM	Wegovy maker to spend £4.9bn on new facilities amid obesity drug race (The Telegraph)
08:11AM	AstraZeneca (AZN) Buys Global Rights to Oral Obesity Candidate (Zacks)
08:05AM	AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View (Zacks)
Nov-09-23 07:37PM	PRESS DIGEST-British Business - Nov. 10 (Reuters)
06:00PM	AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript (Motley Fool)
05:10PM	Medicare drug price negotiations: AstraZeneca CEO's take (Yahoo Finance Video)
05:02PM	AstraZeneca Is Making A $2 Billion Bet To Rival Lilly, Novo In Obesity Drugs (Investor's Business Daily)
01:56PM	The battle for weight loss drug dominance is heating up. Here's why. (Yahoo Finance)
01:25PM	Petrol garages under fire over rising margins at the pump (The Telegraph)
01:16PM	Analyst Report: AstraZeneca PLC (Morningstar Research)
01:01PM	AstraZeneca bets on weight-loss pill to compete with wave of new miracle jabs (The Telegraph)
12:39PM	AstraZeneca enters weight-loss market with oral GLP-1 drug (Yahoo Finance Video)
12:01PM	AstraZeneca Strikes a Deal for an Experimental Weight-Loss Drug and Boosts Its Guidance (Investopedia)
11:09AM	AstraZeneca CFO: Obesity Market Has a Lot of Potential (Bloomberg)
10:57AM	AstraZeneca Is Getting Into the Weight-Loss Drug Game. The Stock Needs a Boost. (Barrons.com)
09:30AM	Astrazeneca (AZN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:00AM	IMFINZI® (durvalumab) plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolization in EMERALD-1 Phase III trial (Business Wire)
05:52AM	Astrazeneca: Q3 Earnings Snapshot (Associated Press Finance)
05:38AM	AstraZeneca signs deal for oral obesity drug and lifts profit outlook (Financial Times)
04:42AM	UPDATE 2-European shares hit 3-week high on earnings boost (Reuters)
04:20AM	AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug (FierceBiotech.com)
03:51AM	AstraZeneca to develop new weight-loss drug after striking £1.6bn deal (The Telegraph)
02:49AM	UPDATE 1-China health sector sees better sentiment from anti-graft drive - execs (Reuters)
02:39AM	UPDATE 3-AstraZeneca raises stakes in obesity drug race with Eccogene deal (Reuters)
02:35AM	AstraZeneca Raises Core EPS Guidance Despite Profit Miss (The Wall Street Journal)
02:05AM	AstraZeneca ups profit outlook and boosts anti-obesity pipeline (Reuters)
01:52AM	China health sector sees better sentiment from anti-graft drive - execs (Reuters)
Nov-08-23 01:27PM	Cellectis S.A. (NASDAQ:CLLS) Q3 2023 Earnings Call Transcript (Insider Monkey)
10:35AM	AstraZeneca reports, Li Auto earnings, Tapestry: 3 things to watch (Investing.com)
07:00AM	AstraZeneca to leverage its global industrial-scale manufacturing and digital capabilities to boost US renewable natural gas productivity (Business Wire)
Nov-07-23 11:29AM	U.S. FTC disputes Orange Book listing for some drug patents (Reuters)
10:01AM	Q3 2023 FibroGen Inc Earnings Call (Thomson Reuters StreetEvents)
07:00AM	Compugen Reports Third Quarter 2023 Results (PR Newswire)
Nov-06-23 01:23PM	AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards? (Zacks)
10:51AM	Pharma Stocks Are Bleeding. But These 2 Look Like Bargains. (Barrons.com)
10:05AM	Unlocking Q3 Potential of Astrazeneca (AZN): Exploring Wall Street Estimates for Key Metrics (Zacks)
Nov-05-23 07:08AM	12 Best Large Cap Stocks To Buy Now (Insider Monkey)
Nov-03-23 11:30AM	Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial (Business Wire)
10:06AM	AstraZeneca's failed cancer drug gets new lease on life thanks to positive kidney disease data (FierceBiotech.com)
05:09AM	Q3 2023 Ionis Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-02-23 09:00AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Nov-01-23 08:02AM	AstraZeneca takes 22% stake in Cellectis as part of collab for 10 cell and gene therapies (FierceBiotech.com)
07:00AM	Health Canada approves Ultomiris for adults with neuromyelitis optica spectrum disorder (NMOSD) (PR Newswire)
03:00AM	Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca (GlobeNewswire)
Oct-31-23 05:50PM	Astrazeneca (AZN) Rises But Trails Market: What Investors Should Know (Zacks)
Oct-30-23 04:35PM	13 Most Undervalued Pharma Stocks To Buy According To Analysts (Insider Monkey)
09:30AM	Can Diabetes, Weight-Loss Drugs Get Even Better (PR Newswire)
09:00AM	Is Trending Stock AstraZeneca PLC (AZN) a Buy Now? (Zacks)
06:09AM	Merck pays $169M for selective PARP1 drug, stepping up challenge to AstraZeneca and Gilead (FierceBiotech.com)
05:25AM	11 Best Immunotherapy Stocks To Buy Now (Insider Monkey)
Oct-28-23 06:50AM	3 No-Brainer Stocks to Buy for Under $100 Right Now (Motley Fool)

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZN

Astrazeneca plc ADR

Upgrade your FINVIZ experience